4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-25-309641
Chief Medical Officer sold 880 shares at $20.72 ($18,234)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kerr Douglas Chief Medical Officer | 2025-12-05 | Sale 10b5-1 | −880 | $20.72 | $18,234 | 87,510 | D |
| Open-market sales · 880 sh · avg $20.72 · $18,234 | |||||||
Loading xslF345X05/ownership.xml…